Logo
L

LYSOGENE

21 employees

Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Gene Therapy
Lysosomal Storage Disease
Medical
Health Care
Central Nervous System Pathology
AAV vector

Date founded

2009

Funding rounds raised

Total raised

$22M

from 3 investors over 3 rounds

L

LYSOGENE raised $3.4M on December 24, 2021

Investors: European Investment Bank

L

LYSOGENE raised $22M on May 21, 2014

Investors: Sofinnova Ventures, Russia technology fund and Novo Holdings

FAQ